LUCIANO COSTA: Open Payments
NPI 1477606309 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$90,871 in 53 payments from 10 companies in 2025. Trend: 2023 $29,728 · 2024 $40,345 · 2025 $90,871
Consulting: $73,154Travel & lodging: $11,855Speaker / faculty: $5,040Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 21 | $42,219 |
| Regeneron Pharmaceuticals, Inc. | 8 | $22,443 |
| PFIZER INC. | 3 | $9,135 |
| Janssen Global Services, LLC | 11 | $7,813 |
| Janssen Research & Development, LLC | 2 | $2,620 |
| ABBVIE INC. | 2 | $2,237 |
| Adaptive Biotechnologies Corporation | 1 | $2,000 |
| Genentech, Inc. | 2 | $1,520 |
| AstraZeneca Pharmaceuticals LP | 1 | $820 |
| Celgene Corporation | 2 | $65 |
Products named: LYNOZYFIC, DARZALEX, IBRANCE, TECVAYLI, clonoSEQ, ELREXFIO.
Industry payments across AL — which companies pay providers there.
